These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 10974321)
21. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor. Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659 [TBL] [Abstract][Full Text] [Related]
22. Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition. Lopes LV; Cunha RA; Kull B; Fredholm BB; Ribeiro JA Neuroscience; 2002; 112(2):319-29. PubMed ID: 12044450 [TBL] [Abstract][Full Text] [Related]
23. G protein coupling of CGS 21680 binding sites in the rat hippocampus and cortex is different from that of adenosine A1 and striatal A2A receptors. Cunha RA; Constantino MD; Ribeiro JA Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):295-302. PubMed ID: 10344528 [TBL] [Abstract][Full Text] [Related]
24. On the high affinity binding site for [3H]-1,3-dipropyl-8-cyclopentylxanthine in frog brain membranes. Oliveira JC; Sebastião AM; Ribeiro JA Br J Pharmacol; 1993 Jun; 109(2):518-23. PubMed ID: 8358551 [TBL] [Abstract][Full Text] [Related]
25. Kinetic and functional properties of [3H]ZM241385, a high affinity antagonist for adenosine A2A receptors. Uustare A; Vonk A; Terasmaa A; Fuxe K; Rinken A Life Sci; 2005 Feb; 76(13):1513-26. PubMed ID: 15680315 [TBL] [Abstract][Full Text] [Related]
26. [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors. Varani K; Merighi S; Gessi S; Klotz KN; Leung E; Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Borea PA Mol Pharmacol; 2000 May; 57(5):968-75. PubMed ID: 10779381 [TBL] [Abstract][Full Text] [Related]
27. In vivo labelling of the adenosine A2A receptor in mouse brain using the selective antagonist [3H]SCH 58261. El Yacoubi M; Ledent C; Parmentier M; Ongini E; Costentin J; Vaugeois JM Eur J Neurosci; 2001 Nov; 14(9):1567-70. PubMed ID: 11722618 [TBL] [Abstract][Full Text] [Related]
28. Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. Merighi S; Varani K; Gessi S; Cattabriga E; Iannotta V; Ulouglu C; Leung E; Borea PA Br J Pharmacol; 2001 Nov; 134(6):1215-26. PubMed ID: 11704641 [TBL] [Abstract][Full Text] [Related]
29. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists. Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787 [TBL] [Abstract][Full Text] [Related]
30. A new series of 2-alkoxy(aralkoxy)-[1,2,4]triazolo[1,5-a]quinazolin-5-ones as adenosine receptor antagonists. Al-Salahi R; Geffken D; Koellner M Chem Pharm Bull (Tokyo); 2011; 59(6):730-3. PubMed ID: 21628909 [TBL] [Abstract][Full Text] [Related]
31. 125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor. Palmer TM; Poucher SM; Jacobson KA; Stiles GL Mol Pharmacol; 1995 Dec; 48(6):970-4. PubMed ID: 8848012 [TBL] [Abstract][Full Text] [Related]
32. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes. Nonaka H; Mori A; Ichimura M; Shindou T; Yanagawa K; Shimada J; Kase H Mol Pharmacol; 1994 Nov; 46(5):817-22. PubMed ID: 7969067 [TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists. Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033 [TBL] [Abstract][Full Text] [Related]
34. Characterisation of central adenosine A(1) receptors and adenosine transporters in mice lacking the adenosine A(2a) receptor. Snell BJ; Short JL; Drago J; Ledent C; Lawrence AJ Brain Res; 2000 Sep; 877(2):160-9. PubMed ID: 10986328 [TBL] [Abstract][Full Text] [Related]
35. Autoradiographic visualization of A1 adenosine receptors in rat brain with [3H]8-cyclopentyl-1,3-dipropylxanthine. Weber RG; Jones CR; Lohse MJ; Palacios JM J Neurochem; 1990 Apr; 54(4):1344-53. PubMed ID: 2313291 [TBL] [Abstract][Full Text] [Related]
36. Adenosine A2A receptors regulate the extracellular accumulation of excitatory amino acids upon metabolic dysfunction in chick cultured retinal cells. Rego AC; Agostinho P; Melo J; Cunha RA; Oliveira CR Exp Eye Res; 2000 May; 70(5):577-87. PubMed ID: 10870516 [TBL] [Abstract][Full Text] [Related]
37. The binding of 1,3-[3H]-dipropyl-8-cyclopentylxanthine to adenosine A1 receptors in rat smooth muscle preparations. Peachey JA; Hourani SM; Kitchen I Br J Pharmacol; 1994 Dec; 113(4):1249-56. PubMed ID: 7889280 [TBL] [Abstract][Full Text] [Related]
38. Diverse inhibitors of intracellular signalling act as adenosine receptor antagonists. Schulte G; Fredholm BB Cell Signal; 2002 Feb; 14(2):109-13. PubMed ID: 11781134 [TBL] [Abstract][Full Text] [Related]
39. Site-directed mutagenesis studies of human A(2A) adenosine receptors: involvement of glu(13) and his(278) in ligand binding and sodium modulation. Gao ZG; Jiang Q; Jacobson KA; Ijzerman AP Biochem Pharmacol; 2000 Sep; 60(5):661-8. PubMed ID: 10927024 [TBL] [Abstract][Full Text] [Related]
40. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Klotz KN; Hessling J; Hegler J; Owman C; Kull B; Fredholm BB; Lohse MJ Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):1-9. PubMed ID: 9459566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]